ICLR — ICON PLC
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1060955 ·
Last close
$163.57
Market Cap
$12.62B
52W High
$186.64
52W Low
$108.80
ADV30
965,630
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 2,063,486,000 | 479,294,000 | 194,209,000 | 72,582,000 | 16,400,320,000 | 928,385,000 | 7,022,158,000 |
| Mar 2026 | 2,033,999,000 | 477,926,000 | 186,997,000 | 104,751,000 | 16,319,022,000 | 765,164,000 | 7,018,726,000 |
| Dec 2025 | 2,112,517,000 | 480,738,000 | 210,748,000 | 149,194,000 | 16,269,782,000 | 647,295,000 | 7,076,398,000 |
| Sep 2025 | 2,042,812,000 | 554,448,000 | 258,904,000 | 2,355,000 | 16,507,490,000 | 468,888,000 | 7,172,644,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,140,357,000
Investing CF
$-200,477,000
Financing CF
$-1,169,422,000
CapEx
$-176,173,000
Dividends Paid
—
Buybacks
$-1,149,998,000
EPS Diluted TTM
$7.39
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$2,313,835,000
Inventory
—
Receivables
$2,799,040,000
ST Investments
—
EBIT TTM
$789,963,000
Pretax Income TTM
$621,570,000
Interest Exp TTM
$168,393,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,294,416,896
EBITDA
$523,480,992
Free Cash Flow
$655,146,624
Enterprise Value
$15,184,677,888
Total Cash
$928,385,024
Total Debt
$3,493,335,040
Shares Out
77,154,209
Trailing EPS
$0.65
Book Value
$121.41
ROE
0.3%
ROA
1.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,251,340,000 | 1,012,459,000 | 229,339,000 | 16,269,782,000 | 7,076,398,000 | — | 1,036,205,000 |
| Dec 2024 | 8,188,990,000 | 1,154,081,000 | 739,126,000 | 16,634,822,000 | 7,193,468,000 | — | 1,286,652,000 |
| Dec 2023 | 8,054,926,000 | 994,230,000 | 554,208,000 | 16,864,783,000 | 7,653,337,000 | — | 1,161,027,000 |
| Dec 2022 | 7,741,386,000 | 866,075,000 | 505,304,000 | 17,185,278,000 | 8,687,315,000 | — | 563,315,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$11.86
Max Pain — expiry 2026-08-21
max pain strike: $175.00 · spot: $163.57 · call oi: 2,960 · put oi: 3,813
Expected Move to 2026-08-21:
±$15.10
(9.23%) —
implied range
$148.47 –
$178.67
· ATM straddle on $165.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $11.20B | $232.51 | — |
| MEDP | Medpace Holdings, Inc. | $16.11B | $577.11 | — |
| INCY | INCYTE CORP | $24.23B | $119.52 | — |
| LNTH | Lantheus Holdings, Inc. | $6.49B | $99.64 | — |
| IQV | IQVIA HOLDINGS INC. | $38.68B | $235.02 | — |
News headlines (Yahoo Finance, 1h cache)
ICON Public Limited Company (ICLR) Surges on Net Book-to-Bill Strength
2026-07-29 13:16 · Yahoo
ICON (ICLR) Stock May Be 33% Undervalued After Earnings Review Uncertainty
2026-07-09 01:12 · Yahoo
ICON Public Limited Company (ICLR) Fell Due to Uncertainty Surrounding Reported Earnings
2026-07-08 11:41 · Yahoo
Icon Reestablishes 'Credible' Path to Growth in 2027, RBC Capital Markets Says
2026-06-25 15:10 · Yahoo
Company News for Jun 25, 2026
2026-06-25 13:23 · Yahoo
ICON Announces Multi-Year Anthropic Collaboration to Expand AI Across Clinical Trials
2026-07-28 14:04 · Yahoo
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
2026-07-28 11:00 · Yahoo
ICON Announces Results of Annual General Meeting
2026-07-31 20:15 · Yahoo
Icon PLC (ICLR) (Q2 2026) Earnings Call Highlights: Strong Bookings Surge Amid Margin Pressures
2026-07-30 19:03 · Yahoo
ICON Reports Second Quarter 2026 Results
2026-07-29 20:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.